115 related articles for article (PubMed ID: 6203858)
1. Effects of intradermal administration of streptococcal preparation OK-432 on interferon and natural killer cell activities in patients with oral cancer.
Sato M; Yoshida H; Yanagawa T; Yura Y; Urata M; Atsumi M; Hayashi Y; Takegawa Y
Int J Oral Surg; 1984 Feb; 13(1):7-15. PubMed ID: 6203858
[TBL] [Abstract][Full Text] [Related]
2. In vitro potentiation of human natural killer cell activity by a streptococcal preparation, OK-432: interferon and interleukin-2 participation in the stimulation with OK-432.
Wakasugi H; Kasahara T; Minato N; Hamuro J; Miyata M; Morioka Y
J Natl Cancer Inst; 1982 Oct; 69(4):807-12. PubMed ID: 6181282
[TBL] [Abstract][Full Text] [Related]
3. Interferon activity and its characterization in the sera of patients with head and neck cancer.
Sato M; Yoshida H; Yanagawa T; Yura Y; Urata M; Atsumi M; Furumoto N; Hayashi Y; Takegawa Y
Cancer; 1984 Oct; 54(7):1239-51. PubMed ID: 6205740
[TBL] [Abstract][Full Text] [Related]
4. Modulation of NK activity in regional lymph nodes by preoperative immunotherapy with OK-432 in patients with cancer of the oral cavity.
Vinzenz K; Matejka M; Watzek G; Porteder H; Neuhold N; Micksche M
Cancer Detect Prev Suppl; 1987; 1():463-75. PubMed ID: 3480060
[TBL] [Abstract][Full Text] [Related]
5. Augmentation of natural killer (NK) cell activity by a streptococcal preparation, OK-432, in patients with malignant tumors.
Wakasugi H; Oshimi K; Miyata M; Morioka Y
J Clin Immunol; 1981 Jul; 1(3):154-62. PubMed ID: 6174541
[TBL] [Abstract][Full Text] [Related]
6. Natural killer (NK) cell activating factor released from murine thymocytes stimulated with an anti-tumor streptococcal preparation, OK-432.
Shitara K; Ichimura O; Mitsuno T; Osawa T
J Immunol; 1985 Feb; 134(2):1039-47. PubMed ID: 2578148
[TBL] [Abstract][Full Text] [Related]
7. [Successful adoptive immunotherapy with OK432-inducible activated natural killer cells on tumor-bearing mice].
Yamaue H; Tanimura H; Iwahashi M; Tani M; Tsunoda T; Tabuse K
Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2546-55. PubMed ID: 2614190
[TBL] [Abstract][Full Text] [Related]
8. [Antitumor effect of OK-432 (1)--antitumor effect of OK-432 induced interferon-gamma (IFN gamma)].
Saito M; Yamaguchi T; Aonuma E; Noda T; Edina T; Ishida N
Gan To Kagaku Ryoho; 1982 Nov; 9(11):2031-7. PubMed ID: 6820888
[TBL] [Abstract][Full Text] [Related]
9. [Enhancing effects on interferon-gamma production by combination of OK-432 and interferon-alpha in patients with head and neck cancer].
Sugiyama M; Morisaki N; Konishi K; Go K; Sugita M; Nakai Y
Gan To Kagaku Ryoho; 1984 Oct; 11(10):2200-6. PubMed ID: 6435540
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of the routes of administration of a streptococcal preparation, OK-432--with special reference to augmentation of the natural killer cell activity].
Hosoi J; Wakasugi H; Miyata M; Minato N; Imai M
Nihon Gan Chiryo Gakkai Shi; 1982 Dec; 17(8):2044-55. PubMed ID: 7169577
[No Abstract] [Full Text] [Related]
11. In vitro augmentation of natural killing activity by OK-432.
Uchida A; Micksche M
Int J Immunopharmacol; 1981; 3(4):365-75. PubMed ID: 6174467
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of NK activation by OK-432 (Streptococcus pyogenes). I. Spontaneous release of NKCF and augmentation of NKCF production following stimulation with NK target cells.
Bonavida B; Katz J; Hoshino T
Cell Immunol; 1986 Oct; 102(1):126-35. PubMed ID: 3492275
[TBL] [Abstract][Full Text] [Related]
13. Characterization of mouse natural killer cell activating factor (NKAF) induced by OK-432: evidence for interferon- and interleukin 2-independent NK cell activation.
Ichimura O; Suzuki S; Sugawara Y; Osawa T
Br J Cancer; 1984 Jul; 50(1):97-108. PubMed ID: 6204667
[TBL] [Abstract][Full Text] [Related]
14. Generation of activated killer-like cells by OK-432-mediated production of interleukin 1, interleukin 2, and interferon-gamma in vitro.
Ujiie T
Jpn J Exp Med; 1987 Dec; 57(6):333-8. PubMed ID: 3131563
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy for renal cell carcinoma using IFN-gamma and OK-432: in vitro study.
Muraki J
Keio J Med; 1990 Mar; 39(1):21-5. PubMed ID: 2113148
[TBL] [Abstract][Full Text] [Related]
16. Tumoricidal effect of human PBMC following stimulation with OK-432 and its application for locoregional immunotherapy in head and neck cancer patients.
Kubota E; Katano M; Kurokawa H; Imamura H; Katsuki T; Yamamoto H; Hisatsugu T; Nagumo F; Tadano J
J Craniomaxillofac Surg; 1993 Jan; 21(1):30-7. PubMed ID: 8445052
[TBL] [Abstract][Full Text] [Related]
17. Effects of interleukin-2, OK-432 and interferon-gamma on in vitro induction of nonspecific killer cells by concanavalin A in mice.
Mizushima Y; Iwata M; Sato M; Yano S
Tohoku J Exp Med; 1986 Jan; 148(1):79-85. PubMed ID: 3085284
[TBL] [Abstract][Full Text] [Related]
18. [Oral administration of OK-432 (picibanil). (8th report) clinical application: its immunomodulatory effects on the patients with gastrointestinal cancers].
Nio Y; Ohgaki K; Tsuchitani T; Imai S; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Tobe T
Nihon Gan Chiryo Gakkai Shi; 1989 Aug; 24(8):1607-15. PubMed ID: 2809385
[TBL] [Abstract][Full Text] [Related]
19. Effect of soluble factors derived from oral cancer cells on the production of interferon-γ from peripheral blood mononuclear cells following stimulation with OK-432.
Ohe G; Sasai A; Uchida D; Tamatani T; Nagai H; Miyamoto Y
Oncol Rep; 2013 Aug; 30(2):945-51. PubMed ID: 23685791
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of natural killer cell activity in human immunodeficiency virus-infected subjects by in vitro treatment with biologic response modifier OK-432.
Huang XL; Fan Z; Murayama T; Rinaldo C
Clin Diagn Lab Immunol; 1995 Jan; 2(1):91-7. PubMed ID: 7719919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
